T1	Participants 33 67	retinal angiomatous proliferation:
T2	Participants 166 205	retinal angiomatous proliferation (RAP)
T3	Participants 355 421	Thirty-four patients with RAP with any stage of neovascularization
T4	Participants 1460 1478	patients with RAP.
